Found: 9
Select item for more details and to access through your institution.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 1, p. 229, doi. 10.1007/s10549-022-06713-1
- By:
- Publication type:
- Article
Participant Evaluation of a Multi-disciplinary Oncology Preceptorship Training Program for Oncology Health Professionals from Kumasi, Ghana.
- Published in:
- Journal of Cancer Education, 2024, v. 39, n. 4, p. 360, doi. 10.1007/s13187-024-02417-w
- By:
- Publication type:
- Article
Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0044-4
- By:
- Publication type:
- Article
Cutaneous presentation of a distant metastasis of malignant phyllodes tumor.
- Published in:
- International Journal of Dermatology, 2012, v. 51, n. 1, p. 72, doi. 10.1111/j.1365-4632.2011.04923.x
- By:
- Publication type:
- Article
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 11, p. 2557, doi. 10.1002/cncr.20653
- By:
- Publication type:
- Article
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia.
- Published in:
- Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/146938
- By:
- Publication type:
- Article
729. Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S281, doi. 10.1016/j.ymthe.2006.08.809
- By:
- Publication type:
- Article